Provided by Tiger Trade Technology Pte. Ltd.

Chiasma

3.76
0.0000
Volume:- -
Turnover:- -
Market Cap:217.72M
PE:-2.39
High:3.76
Open:3.76
Low:3.76
Close:3.76
52wk High:5.74
52wk Low:2.77
Shares:57.90M
Float Shares:33.20M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.5732
EPS(LYR):-1.4316
ROE:-133.81%
ROA:-37.05%
PB:3.47
PE(LYR):-2.63

Loading ...

Company Profile

Company Name:
Chiasma
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Chiasma, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing oral medications using transient permeability enhancer technology platform for the treatment of rare and serious chronic disease worldwide. The company offers MYCAPSSA, an oral octreotide capsule for the long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide. It also develops MPOWERED, an oral octreotide capsule, which has completed Phase III clinical trials for the maintenance treatment of adult patients with acromegaly. Chiasma, Inc. was incorporated in 2001 and is headquartered in Needham, Massachusetts.